Related Experiment Video
Updated: May 7, 2026
07:51
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
Published on: May 21, 2018
Multicomponent reactions - opportunities for the pharmaceutical industry
Drug Discovery Today. Technologies
|September 21, 2013
Summary
Multicomponent reactions offer efficient synthesis of drug candidates for discovery and optimization. Their green chemistry advantages also support sustainable pharmaceutical production.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Green Chemistry
Background:
- Multicomponent reactions (MCRs) combine three or more reactants in one pot to form a single product.
- MCRs are valuable tools in drug discovery for generating diverse molecular libraries.
- The inherent efficiency and atom economy of MCRs align with green chemistry principles.
Purpose of the Study:
- To review recent advancements in multicomponent reactions for medicinal chemistry.
- To highlight the role of MCRs in drug discovery and lead optimization.
- To discuss the application of MCRs in sustainable pharmaceutical manufacturing.
Main Methods:
- Literature review of recent developments in multicomponent reactions.
- Analysis of MCR applications in drug discovery and lead optimization.
- Evaluation of the green chemistry aspects of MCRs in pharmaceutical synthesis.
Main Results:
- MCRs provide rapid access to a wide array of analogs for drug discovery.
- The efficiency of MCRs accelerates lead optimization processes.
- MCRs contribute to environmentally friendly pharmaceutical production methods.
Conclusions:
- Multicomponent reactions are powerful tools for both drug discovery and sustainable pharmaceutical manufacturing.
- Continued development of MCRs will further enhance their utility in medicinal chemistry.
- Addressing barriers to MCR implementation is key for broader adoption in the industry.
Related Concept Videos
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:17Drug Metabolism: Phase I Reactions
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
01:15Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems
Oxidative reactions are pivotal in metabolizing numerous compounds, including pharmaceutical drugs. These reactions often occur in carbon-heteroatom systems, such as carbon-nitrogen, carbon-sulfur, and carbon-oxygen.
In carbon-nitrogen systems, aliphatic and aromatic amines can undergo oxidative reactions. Secondary and tertiary amines, like those found in tricyclic antidepressants, can undergo N-dealkylation, a process that involves the oxidation of the alkyl group. In addition, oxidative...
In carbon-nitrogen systems, aliphatic and aromatic amines can undergo oxidative reactions. Secondary and tertiary amines, like those found in tricyclic antidepressants, can undergo N-dealkylation, a process that involves the oxidation of the alkyl group. In addition, oxidative...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...